Vendor Intelligence Report: Lux Synth Aminos

Executive summary

Across 6 Finnrick lab tests, Lux Synth Aminos has 4 passes and 2 failures — a 67% overall pass rate. The record is split, not merely average: Retatrutide is the measured bright spot, while Tesamorelin fails both tested samples and remains the product-specific avoid signal. Because these were vendor-submitted samples and the ratings move under stricter grading, the lab data is directional rather than a retail-match guarantee.

The storefront investigation points to a newly visible operation, not a seasoned vendor with a long quiet public history. WHOIS, certificate-transparency, and archive records put the Lux Synth domain in a recent launch window, with registrant privacy, Shopify hosting, a Gmail contact, and a Delaware virtual mailbox. Checked corporate registries did not verify a matching Lux Synth Aminos entity.

The buyer-recourse problem is broader than domain age. Lux Synth product pages borrow legal-term infrastructure from another peptide vendor, while directory and archive records tie the brand environment to Luxe Aminos / Maxim Labz. The site also lacks public Lux Synth batch-level COAs, has broken buyer-policy pages, and uses coded catalog names including GLP R, GLP T, and distorted Tesamorelin labels.

For buyers, this is a narrow product-specific file: Retatrutide may be worth considering only with batch-number and COA matching; Tesamorelin should not be bought from this vendor on the current record. The full report resolves the brand-network trail, policy gaps, COA inconsistencies, and catalog controls behind that recommendation.

Inside the full report:

• Appendix A per-product pass/fail rates and methodology-divergence charts for both tested products
• WHOIS, DNS, certificate-transparency, and Wayback artifacts documenting the launch footprint
• Corporate-registry search log across Delaware, New York, Florida, and OpenCorporates
• Brand-network evidence connecting Lux Synth Aminos, Liberty Peptides, Luxe Aminos, and Maxim Labz
• Catalog and label exhibits covering coded product names, the live placeholder item, and batch-traceability gaps
• COA-access review comparing Lux Synth Aminos with related Luxe Aminos Chromate Labs exhibits

Risk assessment

• Tesamorelin quality risk — high: Tesamorelin has 2 Finnrick tests, 0 passes, and a 41.58% rating; avoid this product from Lux Synth Aminos unless new independent retail testing changes the record.
• Batch-verification and COA transparency risk — high: No public Lux Synth Aminos batch-level COAs or visible batch-number matching were found; Finnrick samples in the field file were vendor-submitted rather than independently purchased.
• Product-identification and dosing-confusion risk — high: The catalog uses coded names such as GLP R, GLP T, teessssssaaaaa, Tessa, Glow, and Klow, increasing misidentification risk for injectable compounds.
• Corporate accountability and buyer-recourse risk — high: No matching Lux Synth Aminos entity was found in checked registries; the domain is privacy-masked, the contact is Gmail, the address is a virtual mailbox, and refund/terms/shipping pages returned 404.
• Brand/channel confusion risk — medium: Lux Synth pages link to Liberty Peptides terms and PeptideBenchmark lists a Luxe Aminos MyShopify domain as the official Lux Synth site; no authoritative official-channel or anti-counterfeit framework was captured.